Trial Details
COMPLETEDBasic Information
| Clinical ID | c1583 |
|---|---|
| Identifier | NCT05088369 |
| Trial Title | Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: HM201|DRUG: Placebo|DRUG: HM201|DRUG: Placebo |
Participant Information
| Sponsor | Syneos Health |
|---|---|
| City | Herston |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2021-11-11 |
|---|---|
| Primary Completion Date | 2022-12-19 |
| Completion Date | 2022-12-19 |